Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 9/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 11/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.47 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | AURKA | O14965 | 1/20 | 0.43 |
| ▸ | JAK2 | O60674 | 1/20 | 0.43 |
| ▸ | JAK1 | P23458 | 1/20 | 0.43 |
| ▸ | TYK2 | P29597 | 1/20 | 0.43 |
| ▸ | TTK | P33981 | 1/20 | 0.43 |
| ▸ | JAK3 | P52333 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | AURKC | Q9UQB9 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7104515 | 0.84 | ADORA3 (0.64) | SYKADORA3ADORA2AADORA1MEN1 | |
| SCHEMBL7106973 | 0.84 | ADORA3 (0.68) | SYKADORA3ADORA2AADORA1MEN1 | |
| SCHEMBL4917250 | 0.84 | ADORA3 (0.49) | SYKADORA3ADORA2AADORA1MEN1 | |
| SCHEMBL21601510 | 0.81 | ADORA3 (0.69) | SYKADORA3ADORA2AADORA1MEN1 | |
| SCHEMBL21601563 | 0.81 | ADORA3 (0.69) | SYKADORA3ADORA2AADORA1MEN1 | |
| SCHEMBL21601504 | 0.81 | ADORA3 (0.69) | SYKADORA3ADORA2AADORA1MEN1 | |
| SCHEMBL31061104 | 0.81 | ADORA3 (0.69) | SYKADORA3ADORA2AADORA1MEN1 | |
| SCHEMBL13301204 | 0.79 | SYK (0.50) | SYKADORA3ADORA2AADORA1AURKA | |
| SCHEMBL13301205 | 0.79 | MEN1 (0.48) | SYKADORA3ADORA2AADORA1MEN1 | |
| SCHEMBL1223740 | 0.79 | SYK (0.60) | SYKADORA3ADORA2AADORA1AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1200435-B1 | PURINE DERIVATIVES INHIBITORS OF TYROSINE PROTEIN KINASE SYK | NOVARTIS AG (CH) | 2003-10-01 | — | — | EP | disclosed |
| US-6589950-B1 | Treatment of inflammatory or obstructive airways disease for respiratory system disorders | NOVARTIS AG (CH) | 2003-07-08 | — | — | US | disclosed |
| EP-1200435-A1 | PURINE DERIVATIVES INHIBITORS OF TYROSINE PROTEIN KINASE SYK | Novartis AG (CH) | 2002-05-02 | — | — | EP | disclosed |
| WO-2001009134-A1 | PURINE DERIVATIVES INHIBITORS OF TYROSINE PROTEIN KINASE SYK | NOVARTIS AG (CH) | 2001-02-08 | — | — | WO | disclosed |